Skip to main content
NIH funding notice PAR-17-152

Advancing Our Understanding of the Brain Epitranscriptome (R21)

Closed on May 7, 2020.

Posted
February 3, 2017
Close date
May 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $652,338 in first-year total cost, median $237,397.

Most frequent study sections

  1. Molecular Neurogenetics Study Section[MNG]3

Most frequent institutions

  1. BOSTON CHILDREN'S HOSPITAL1
  2. DUKE UNIVERSITY1
  3. UNIVERSITY OF CALIFORNIA, MERCED1
Competing awards under PAR-17-152 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Methods to map the m7G tRNA methylome1R21MH118594-01GREGORY, RICHARD I.BOSTON CHILDREN'S HOSPITAL, MA$265,500MNG
2019Epitranscriptomic Control of Local Gene Expression in Neural Stem Cells1R21MH119813-01MEYER, KATHRYN DSILVER, DEBRADUKE UNIVERSITY, NC$237,397MNG
2018Uncovering the context-dependent complexity of neural RNA modifications1R21MH116415-01CLEARY, MICHAELSPITALE, ROBERT CUNIVERSITY OF CALIFORNIA, MERCED, CA$149,441MNG

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-17-152: Advancing Our Understanding of the Brain Epitranscriptome (R21) | ScienceDex | ConductScience